U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Nucleic Acid
Created
by admin
on Sat Dec 16 18:11:01 GMT 2023
Edited
by admin
on Sat Dec 16 18:11:01 GMT 2023
Nucleic Acid Type RNAI
Nucleic Acid Subtype
Sequence Type COMPLETE
Record UNII
E422BH4BRK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZILEBESIRAN
INN   USAN  
Official Name English
zilebesiran [INN]
Common Name English
ALN-85481
Code English
[(2S,4R)-1-{1-[(2-acetamido-2-deoxy-β-D-galactopyranosyl)oxy]-16,16-bis({3-[(3-{5-[(2- acetamido-2-deoxy-β-D-galactopyranosyl)oxy]pentanamido}propyl)amino]-3-oxopropoxy}methyl)-5,11,18-trioxo-14-oxa-6,10,17- triazanonacosan-29-oyl}-4-hydroxypyrrolidin-
Common Name English
AD-85481
Code English
ZILEBESIRAN [USAN]
Common Name English
ALN-AGT01
Code English
RNA, (Gm-sp-Um-sp-Cm-Am-Um-Cm-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)A-Um-Gm-Am-Gm-Am-Gm-Um-Am-Cm-Am), 3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(ace
Common Name English
Code System Code Type Description
CAS
2380166-33-4
Created by admin on Sat Dec 16 18:11:01 GMT 2023 , Edited by admin on Sat Dec 16 18:11:01 GMT 2023
PRIMARY
INN
11531
Created by admin on Sat Dec 16 18:11:01 GMT 2023 , Edited by admin on Sat Dec 16 18:11:01 GMT 2023
PRIMARY
USAN
KL-80
Created by admin on Sat Dec 16 18:11:01 GMT 2023 , Edited by admin on Sat Dec 16 18:11:01 GMT 2023
PRIMARY
FDA UNII
E422BH4BRK
Created by admin on Sat Dec 16 18:11:01 GMT 2023 , Edited by admin on Sat Dec 16 18:11:01 GMT 2023
PRIMARY
NCI_THESAURUS
C179136
Created by admin on Sat Dec 16 18:11:01 GMT 2023 , Edited by admin on Sat Dec 16 18:11:01 GMT 2023
PRIMARY
Sugar Site Range Site Count
2'-Fluoro-Ribose 1_2;1_14;1_16;2_7;2_9-2_11 7 / 45
2'-O-Methyl-Ribose 1_1;1_3-1_13;1_15;1_17-1_23;2_1-2_6;2_8;2_12-2_22 38 / 45
Linkage Site Range Site Count
Phosporothioate 1_2-1_3;1_22-1_23;2_2-2_3 6 / 43
Phosphate 1_4-1_21;2_4-2_22 37 / 43
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET->INHIBITOR OF EXPRESSION
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOTIDE SUBSTITUTION [1_6] 1-((2S)-1-(2,3-DIHYDROXY)PROPYL)THYMINE-PHOSPHATE 3BH2CF5QM5
NUCLEOTIDE SUBSTITUTION [2_22] ZILEBESIRAN 3'-MODIFICATION UM4X8S48E7